Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
about
Cost-utility analysis of nonalcoholic steatohepatitis screening.Controversies in the Diagnosis and Management of NAFLD and NASH.Cost-effectiveness analysis of ultrasonography screening for nonalcoholic fatty liver disease in metabolic syndrome patientsScreening for Nonalcoholic Steatohepatitis in Individuals with Type 2 Diabetes: A Cost-Effectiveness Analysis.Pharmacological agents for NASH.Pharmacological agents for nonalcoholic steatohepatitis.Therapies for nonalcoholic steatohepatitisEconomic evaluation of a community-based diagnostic pathway to stratify adults for non-alcoholic fatty liver disease: a Markov model informed by a feasibility study.
P2860
Q30385602-B36C1064-AFBA-4F86-83B7-C4283E468A31Q30412296-1CBA5C73-BACF-44FE-8C8E-6BE1F3B84509Q33627037-3CC85AA7-3E4E-4492-BCE0-4BE844C667C6Q37037308-6468F106-5468-41CB-B787-B3B834991565Q38152646-0C4412F5-EDBD-4606-B606-1B7B4194CDF2Q38552387-A68D75A0-0C8D-41B1-A30B-F0D041165160Q38618016-27505129-1B61-4879-B84D-97AF8D6BA41FQ38692351-77BF0FD3-B75A-4853-B45A-43F49E2875BD
P2860
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
@en
type
label
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
@en
prefLabel
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis.
@en
P2860
P50
P356
P1433
P1476
Pioglitazone and vitamin E for nonalcoholic steatohepatitis: a cost utility analysis
@en
P2093
Jacob George
P2860
P304
P356
10.1002/HEP.25887
P407
P577
2012-12-01T00:00:00Z